Business Description
Guobang Pharma Ltd
ISIN : CNE100004NS2
Share Class Description:
SHSE:605507: Class ACompare
Compare
Traded in other countries / regions
605507.China IPO Date
2021-08-02Description
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.7 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 1.12 | |||||
| Interest Coverage | 35.3 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.29 | |||||
| Beneish M-Score | -2.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.8 | |||||
| 3-Year EBITDA Growth Rate | 14.4 | |||||
| 3-Year EPS without NRI Growth Rate | 34.9 | |||||
| 3-Year Book Growth Rate | 32.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.33 | |||||
| 9-Day RSI | 36.75 | |||||
| 14-Day RSI | 40.3 | |||||
| 6-1 Month Momentum % | -12.36 | |||||
| 12-1 Month Momentum % | -32.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.49 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 1.16 | |||||
| Days Inventory | 120.29 | |||||
| Days Sales Outstanding | 42.97 | |||||
| Days Payable | 100.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.09 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| Forward Dividend Yield % | 3.09 | |||||
| 5-Year Yield-on-Cost % | 3.09 | |||||
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | -0.28 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.87 | |||||
| Operating Margin % | 13.56 | |||||
| Net Margin % | 12.17 | |||||
| FCF Margin % | -8.23 | |||||
| ROE % | 9.58 | |||||
| ROA % | 7.33 | |||||
| ROIC % | 12.96 | |||||
| ROC (Joel Greenblatt) % | 17.45 | |||||
| ROCE % | 10.67 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.51 | |||||
| PE Ratio without NRI | 14.69 | |||||
| PS Ratio | 1.9 | |||||
| PB Ratio | 1.47 | |||||
| Price-to-Tangible-Book | 1.55 | |||||
| Price-to-Operating-Cash-Flow | 25.62 | |||||
| EV-to-EBIT | 11.91 | |||||
| EV-to-EBITDA | 11.91 | |||||
| EV-to-Revenue | 1.66 | |||||
| EV-to-FCF | -20.13 | |||||
| Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 4.04 | |||||
| Earnings Yield (Greenblatt) % | 8.4 | |||||
| FCF Yield % | -4.33 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guobang Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,661.054 | ||
| EPS (TTM) (Â¥) | 1.24 | ||
| Beta | 0 | ||
| Volatility % | 13.54 | ||
| 14-Day RSI | 40.3 | ||
| 14-Day ATR (Â¥) | 0.389636 | ||
| 20-Day SMA (Â¥) | 19.488 | ||
| 12-1 Month Momentum % | -32.25 | ||
| 52-Week Range (Â¥) | 18.68 - 29.45 | ||
| Shares Outstanding (Mil) | 558.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guobang Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guobang Pharma Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guobang Pharma Ltd Frequently Asked Questions
What is Guobang Pharma Ltd(SHSE:605507)'s stock price today?
The current price of SHSE:605507 is ¥19.23. The 52 week high of SHSE:605507 is ¥29.45 and 52 week low is ¥18.68.
When is next earnings date of Guobang Pharma Ltd(SHSE:605507)?
The next earnings date of Guobang Pharma Ltd(SHSE:605507) is .
Does Guobang Pharma Ltd(SHSE:605507) pay dividends? If so, how much?
The Dividend Yield %  of Guobang Pharma Ltd(SHSE:605507) is 3.09% (As of Today), Highest Dividend Payout Ratio of Guobang Pharma Ltd(SHSE:605507) was 0.48. The lowest was 0.12. And the median was 0.25. The  Forward Dividend Yield % of Guobang Pharma Ltd(SHSE:605507) is 3.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers